Read the latest interview with QuartzBio's Tobias Guennel to learn more about how generative AI can transform precision medicine data into a force amplifier and decision accelerator. --via Pharma Focus Asia Magazine. https://hubs.ly/Q02Ds3MH0 #generativeAI #precisionmedicine
Precision Medicine Group’s Post
More Relevant Posts
-
Read the latest interview with QuartzBio's Tobias Guennel to learn more about how generative AI can transform precision medicine data into a force amplifier and decision accelerator. --via Pharma Focus Asia Magazine. https://hubs.ly/Q02Ds6LJ0 #generativeAI #precisionmedicine
To view or add a comment, sign in
-
Thrilled to be part of this interview, laying out our vision on how to leverage generative AI to shorten the time from question to insight. Check out the full article via Pharma Focus Asia Magazine. #generativeAI #precisionmedicine
Read the latest interview with QuartzBio's Tobias Guennel to learn more about how generative AI can transform precision medicine data into a force amplifier and decision accelerator. --via Pharma Focus Asia Magazine. https://hubs.ly/Q02Ds6LJ0 #generativeAI #precisionmedicine
To view or add a comment, sign in
-
Please check out our latest blog on Digital Biomarkers. Excelra Sherin Ann Eapen Dr. Manti Kumar Saha, PhD Dr. Debamitra Chakravorty
Are you trying to explore the relationship between biomarker discovery, AI/ML advancements, and digital transformation in medicine? Then you are in the right place. Read our latest blog to learn how the convergence of AI and ML technologies with the quest for digital biomarkers has sparked a paradigm shift in drug discovery and digital medicine. Learn how digitization in healthcare and personalized treatments has led to groundbreaking innovations. Click here to read the full blog: https://lnkd.in/gejKKeSw #Excelra #AI #ML #drugdiscovery #healthcare #biomarkers #biomarkerdiscover #digitaltransformation #pharma #biotech #lifescience
To view or add a comment, sign in
-
Yseop’s CEO, Emmanuel Walckenaer, shares his thoughts on the evolving landscape of AI in pharma in the latest edition of PM360 Magazine. Read his full commentary on page 53: https://lnkd.in/euMkAW4k #AI #MedicalWriting #GenerativeAI #GenAI #Pharma #Data
To view or add a comment, sign in
-
What does the future of healthcare look like? I love the UNITY in thought across the DIVERSITY of experts (John Apathy, Anubhav Srivastava, Ranjit Kumble, Funda Gunes, Ph.D., Sahab Aslam, Rory Kelleher, David West, Kyle Tretina, PhD, Christopher Mason, Daniel Kinney, Jonathan Crowther, Harini Gopalakrishnan shown in this trailer to name just a few) on how AI and emerging technologies will impact this industry in the coming years in our final episode of #AI&US from Dataiku
It seems like a daunting question: “How will AI shape the future of the pharmaceutical industry?” 🏥 But there are practical steps to be taken now, including harnessing #GenerativeAI to advance patient care. Don’t miss the final video in our AI&Us series about the interaction of AI and pharmaceuticals: | https://bit.ly/4bx1vOc | Kelci Miclaus Daniel Kinney Sahab Aslam Ranjit Kumble Harini Gopalakrishnan, Field CTO, Life Sciences at Snowflake, Christopher Mason Anubhav Srivastava Rory Kelleher, Global Head, Business Development for Healthcare and Life Sciences at NVIDIA, Shahar Keinan, CEO and co-founder at POLARISqb, Lurong P., CEO and Founder at Ainnocence, Kyle Tretina, PhD, Alliance Manager at Insilico Medicine, Jonathan Crowther , Gabrielle Samuel, Lecturer, Department of Global Health and Social Medicine at King's College London
To view or add a comment, sign in
-
AI Developer Specializing in Healthcare Equipment Automation | Machine Learning & Cloud Certified | Innovating Medical Technology with AI
🚀 **Exciting Breakthrough in Drug Discovery: The Power of Generative AI!** 🌟 The future of medicine is here, and it's driven by cutting-edge advancements in AI. One of the most remarkable developments in 2024 is the use of Generative AI in drug discovery, particularly in the area of protein folding. 🔬 **Breakthroughs in Protein Folding:** AI models like AlphaFold are revolutionizing the way we understand complex protein structures. By predicting these structures with unprecedented accuracy, we're now able to accelerate drug discovery processes, identifying potential therapeutic targets more quickly than ever before. This leap forward not only speeds up the development of new medications but also opens the door to personalized treatments tailored to individual patients. It's a game-changer for the pharmaceutical industry and a beacon of hope for patients around the world. As we continue to harness the power of AI in healthcare, the possibilities are endless. The intersection of technology and medicine is leading us into a new era of innovation, where treatments are more effective, efficient, and accessible. 💡 Let's embrace these advancements and continue pushing the boundaries of what's possible in healthcare! #AI #HealthcareInnovation #DrugDiscovery #ProteinFolding #GenerativeAI #AlphaFold #PersonalizedMedicine #PharmaTech #FutureOfMedicine
To view or add a comment, sign in
-
In business news, IPA (ImmunoPrecise Antibodies) announced that its subsidiary, BioStrand, is collaborating with PGxAI to leverage BioStrand's patented Foundation AI Model, LENSai. This collaboration advances the precision medicine field of pharmacogenomics and supports LENSai Application Programming Interface commercial rollout through expanding LENSai features and market reach. Despite advancements in generative AI, vector search, and multi-omics, practical applications of precision medicine remain limited. Integrating pharmacogenomics with Electronic Health Records and AI offers significant potential to personalize treatments and enhance patient outcomes. A robust AI model in this field has the potential to revolutionize the $400 billion prescription drug market, significantly improving patient outcomes and driving innovation in precision medicine. https://lnkd.in/db9dCs9F
To view or add a comment, sign in
-
Download the whitepaper and learn how to increase your efficiency
Case Study: ADMAlytics™ powered by tcgmcube How our flagship platform tcgmcube optimized production efficiency & workflows for ADMA Biologics' leveraging the power of predictive AI, generative AI and advanced analytics! Download here: https://lnkd.in/gADd2xcG Key Highlights: Plasma Pool Optimization: Learn how mixed integer programming optimizes plasma unit selection, ensuring optimal batch yields and efficiency. Enhanced Inventory Management: Understand how advanced analytics streamline donor selection and inventory processes, boosting operational efficiency. Real-time KPI Monitoring: Explore the benefits of dynamic dashboards that provide real-time visibility into key performance indicators, aiding in outlier detection and compliance. Generative AI for Documentation: See how generative AI revolutionizes enterprise search, making information retrieval faster and more accurate. By implementing ADMAlytics™ ADMA Biologics has achieved remarkable advancements in production efficiency, data accessibility, and real-time decision-making. The case study not only highlights these successes but also provides insights into the methodology and architecture behind these innovations. #AI #Biopharmaceuticals #Innovation #OperationalExcellence #ADMAlytics
To view or add a comment, sign in
-
My simplified perspective on #AI in the #drug #discovery process based off of #BCG's 2022 Nature Reviews paper "AI in Small-Molecule Drug Discovery: A Coming Wave"? For a thorough analysis, please refer to "It’s Been a Decade of AI in the Drug Discovery Race. What’s Next?" by Andrii Buvailo, Ph.D. https://lnkd.in/eUdn3u96 https://lnkd.in/eKKVHzMY
To view or add a comment, sign in
-
💡 Want to save time and money in your antibody discovery journey? Look no further than MAbSilico! Our streamlined process eliminates the need for back-and-forth optimization, allowing you to start immediately with lead candidates primed for development. Experience the cost-effective advantage with us: 🌐 mabsilico.com #Antibody #AI #ML #DrugDesign #DrugDiscovery
To view or add a comment, sign in
171,186 followers